
FOLLOWUS
1.1Institute of Oncology, The Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu 214062, China
2.2Department of Oncology, People’s Hospital of Taixing, Taixing, Jiangsu 225400, China
3.3Department of Oncology, The Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu 214062, China
4.4Department of Surgerical Oncology, The Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu 214062, China
*Corresponding author Lihua Li Tel: 86-510-88683507, Fax: 86-510-85808820, E-mail: LLHWXSY@aliyun.com; Zijian Guo Tel: 86-510-88682119, E-mail: gzjwxsy@sina.com
网络出版日期:2017-04-11,
纸质出版日期:2017-04
Scan QR Code
microRNA-18a Promotes Cell Migration and Invasion Through Inhibiting Dicer l Expression in Hepatocellular Carcinoma
Zhang Xiufen, Yu Bo, Zhang Fuzheng, et al. microRNA-18a Promotes Cell Migration and Invasion Through Inhibiting Dicer l Expression in Hepatocellular Carcinoma
microRNA-18a Promotes Cell Migration and Invasion Through Inhibiting Dicer l Expression in Hepatocellular Carcinoma
Zhang Xiufen, Yu Bo, Zhang Fuzheng, et al. microRNA-18a Promotes Cell Migration and Invasion Through Inhibiting Dicer l Expression in Hepatocellular Carcinoma
Objective
To investigate the effects of microRNA-18a (miR-18a) on migration and invasion of hepatocellular carcinoma (HCC) cells
and its possible mechanism associated with Dicer l.
Methods
HepG2 and HepG2.2.15 cells were transfected with miR-18a inhibitor using Lipofectamine. Cell invasion was evaluated by transwell invasion assay
and cell migration was detected by transwell migration and wound-healing assays. Moreover
luciferase reporter assay was used to identify whether Dicer expression was regulated by miR-18a. Real-time RT-PCR and western blot were performed to analyze Dicer 1 expression. In addition
a functional restoration assay was performed to investigate whether miR-18a promotes HCC cell migration and invasion by directly targeting Dicer 1.
Results
miR-18a inhibitor can suppress the migration and invasion of HCC cells. Furthermore
suppression of Dicer l expression by small interfering RNA essentially abolished the inhibition of cell migration and invasion induced by miR-18a inhibitor
restorating these activities to levels similar to the parental HCC cells. Interestingly
suppression of miR-18a in HCC cells resulted in enhanced expression of Dicer l. In addition
the results of a luciferase assay demonstrated targeted regulation of Dicer l by miR-18a.
Conclusion
Our findings suggest that miR-18a promotes migration and invasion of HCC cells by inhibiting Dicer l expression.
Forner A , Hessheimer AJ , Isabel Real M , et al. Treatment of hepatocellular carcinoma. Crit Rev Oncol Hematol 2006 ; 60 : 89 - 98 .
Ferenci P , Fried M , Labrecque D , et al. World Gastroenterology Organisation Guideline. Hepatocellular carcinoma (HCC): a global perspective. J Gastrointestin Liver Dis 2010 ; 19 : 311 - 7 .
Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009 ; 136 : 215 - 33 .
Shukla GC , Singh J , Barik S. MicroRNAs: processing, maturation, target recognition and regulatory functions. Mol Cell Pharmacol 2011 ; 3 : 83 - 92 .
Lu J , Getz G , Miska EA , et al. MicroRNA expression profiles classify human cancers. Nature 2005 ; 435 : 834 - 8 .
Landgraf P , Rusu M , Sheridan R , et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007 ; 129 : 1401 - 14 .
Lin M , Chen W , Huang J , et al. MicroRNA expression profiles in human colorectal cancers with liver metastases. Oncol Rep 2011 ; 25 : 739 - 47 .
Li Z , Gu X , Fang Y , et al. microRNA expression profiles in human colorectal cancers with brain metastases. Oncol Lett 2012 ; 3 : 346 - 50 .
He L , Thomson JM , Hemann MT , et al. A microRNA polycistron as a potential human oncogene. Nature 2005 ; 435 : 828 - 33 .
Hayashita Y , Osada H , Tatematsu Y , et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 2005 ; 65 : 9628 - 32 .
Bandres E , Cubedo E , Agirre X , et al. Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 2006 ; 5 : 29 .
Volinia S , Calin GA , Liu CG , et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Nat Acad Sci USA 2006 ; 103 : 2257 - 61 .
Murakami Y , Yasuda T , Saigo K , et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006 ; 25 : 2537 - 45 .
Kutay H , Bai S , Datta J , et al. Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem 2006 ; 99 : 671 - 8 .
Li L , Guo Z , Wang J , et al. Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening. Dig Dis Sci 2012 ; 57 : 2910 - 6 .
Liu WH , Yeh SH , Lu CC , et al. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells. Gastroenterology 2009 ; 136 : 683 - 93 .
Yang F , Yin Y , Wang F , et al. miR-17-5p promotes migration of human hepatocellular carcinoma cells through the p38 mitogen-activated protein kinase-heat shock protein 27 pathway. Hepatology 2010 ; 51 : 1614 - 23 .
Yau WL , Lam CS , Ng L , et al. Over-expression of miR-106b promotes cell migration and metastasis in hepatocellular carcinoma by activating epithelial-mesenchymal transition process. PLoS One 2013 ; 8 : e57882 .
Winter J , Jung S , Keller S , et al. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 2009 ; 11 : 228 - 34 .
Nicholson AW. Dissecting human dicer: some assembly required. J Mol Biol 2012 ; 422 : 464 - 5 .
Kim VN , Han J , Siomi MC. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 2009 ; 10 : 126 - 39 .
Luo Z , Dai Y , Zhang L , et al. miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma. Carcinogenesis 2013 ; 34 : 415 - 25 .
Tao J , Wu D , Li P , et al. microRNA-18a, a member of the oncogenic miR-17-92 cluster, targets Dicer and suppresses cell proliferation in bladder cancer T24 cells. Mol Med Rep 2012 ; 5 : 167 - 72 .
Wu JF , Shen W , Liu NZ , et al. Down-regulation of Dicer in hepatocellular carcinoma. Med Oncol 2011 ; 28 : 804 - 9 .
Kitagawa N , Ojima H , Shirakihara T , et al. Downregulation of the microRNA biogenesis components and its association with poor prognosis in hepatocellular carcinoma. Cancer Sci 2013 ; 104 : 543 - 51 .
Yoshikawa T , Otsuka M , Kishikawa T , et al. Unique haploinsufficient role of the microRNA-processing molecule Dicer1 in a murine colitis-associated tumorigenesis model. PLoS One 2013 ; 8 : e71969 .
Sekine S , Ogawa R , Ito R , et al. Disruption of Dicer1 induces dysregulated fetal gene expression and promotes hepatocarcinogenesis . Gastroenterology 2009 ; 136 : 2304 - 15.e1-4 .
Schultz KA , Yang J , Doros L , et al. DICER1-pleuropul- monary blastoma familial tumor predisposition syndrome: a unique constellation of neoplastic conditions. Pathol Case Rev 2014 ; 19 : 90 - 100 .
Heravi-Moussavi A , Anglesio MS , Cheng SW , et al. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers. N Engl J Med 2012 ; 366 : 234 - 42 .
Bahubeshi A , Bal N , Rio Frio T , et al. Germline DICER1 mutations and familial cystic nephroma. J Med Genet 2010 ; 47 : 863 - 6 .
Witkowski L , Mattina J , Schonberger S , et al. DICER1 hotspot mutations in non-epithelial gonadal tumours. Br J Cancer 2013 ; 109 : 2744 - 50 .
Erler P , Keutgen XM , Crowley MJ , et al. Dicer expression and microRNA dysregulation associate with aggressive features in thyroid cancer. Surgery 2014 ; 156 : 1342 - 50 .
Merritt WM , Lin YG , Han LY , et al. Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med 2008 ; 359 : 2641 - 50 .
Lin RJ , Lin YC , Chen J , et al. microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma. Cancer Res 2010 ; 70 : 7841 - 50 .
Karube Y , Tanaka H , Osada H , et al. Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci 2005 ; 96 : 111 - 5 .
Zhao H , Zhang L , Guo S , et al. Downregulated expression of Dicer1 predicts inferior survival in primary gastrointestinal diffuse large B-cell lymphoma treated with CHOP-like regimen and rituximab. Med Oncol 2014 ; 31 : 206 .
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621